CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | Madaus Martin D Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-18 | Mhatre Rohin Director | Grant or award | +686 | 2,345 | ||
| 2023-05-18 | Mhatre Rohin Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-18 | DAWES KAREN A Director | Grant or award | +798 | 77,199 | ||
| 2023-05-18 | DAWES KAREN A Director | Grant or award · Stock Option (Right to Buy) | +1,730 | 1,730 | ||
| 2023-05-18 | EGLINTON MANNER CARRIE Director | Grant or award | +686 | 2,167 | ||
| 2023-05-18 | EGLINTON MANNER CARRIE Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-18 | BARTHELEMY NICOLAS Director | Grant or award | +686 | 2,767 | ||
| 2023-05-18 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-18 | MUIR GLENN P Director | Grant or award | +686 | 7,582 | ||
| 2023-05-18 | MUIR GLENN P Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-18 | Konstantinov Konstantin Director | Grant or award | +686 | 1,220 | ||
| 2023-05-18 | Konstantinov Konstantin Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2023-05-16 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −710 | $154.03 | $109K | 23,556 |
| 2023-05-16 | Gebski Christine See Remarks | Shares withheld for taxes | −334 | $154.03 | $51K | 32,575 |
| 2023-05-16 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −710 | $154.03 | $109K | 37,381 |
| 2023-05-08 | Madaus Martin D Director | Purchase | +500 | $156.18 | $78K | 1,611 |
| 2023-05-05 | Madaus Martin D Director | Purchase | +500 | $159.19 | $80K | 1,111 |
| 2023-05-04 | Madaus Martin D Director | Purchase | +500 | $161.15 | $81K | 611 |
| 2023-04-04 | Bylund James Chief Operating Officer | Shares withheld for taxes | −334 | $163.45 | $55K | 17,568 |
Page 15 of 23 · 455 trades